Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Please enable cookies. Error 1015 Ray ID: a135b78fedde979a • 2026-06-29 14:45:48 UTC You are being rate limited What happened? The owner of this website (ir.calidibio.com) has banned you temporarily from accessing this website. Please see https://developers.cloudflare.com/support/troubleshooting/http-status-codes/cloudflare-1xxx-errors/error-1015/ for more details. Was this page helpful? Yes No Thank you for your feedback! Cloudflare Ray ID: a135b78fedde979a • Your IP: Click to reveal 81.193.37.7 • Performance & security by Cloudflare